The EU approved a higher Wegovy dose for obesity, boosting weight loss in clinical trials.

Halozyme Therapeutics hit $1.4B in 2025 revenue, driven by soaring royalties from key drugs, with strong growth expected in 2026.

Scientists developed electronic "cyborg" pancreas cells to monitor and boost insulin production in lab-grown islets, advancing diabetes treatment.

St. Jude's CEO James Downing will step down in late 2026 after 12 years, transitioning to a faculty role as a search for his successor begins.

FDA approves new oral combo for untreated CLL, showing better outcomes than chemo.

Novo Nordisk stock dropped 1.6% on Feb. 19, 2026, despite strong earnings and a new oral diabetes drug, due to weak guidance and competition.

Aging men losing Y chromosomes face higher risks of heart disease, cancer, and shorter lives, new study finds.

Kadlec Medical Center now offers the Watchman device, a stroke-prevention implant for atrial fibrillation patients who can’t take blood thinners.

A Chinese laser blood test detects lung cancer years before CT scans, showing promise for early diagnosis.

The NIH is testing ivermectin’s cancer-fighting potential, sparking scientific and political concerns.